Evaluation of a human bio-engineered skin equivalent for drug permeation studies

被引:65
|
作者
Asbill, C
Kim, N
El-Kattan, A
Creek, K
Wertz, P
Michniak, B
机构
[1] Univ S Carolina, Coll Pharm, Dept Basic Pharmaceut Sci, Columbia, SC 29208 USA
[2] Univ S Carolina, Sch Med, Dept Pediat, Childrens Canc Res Lab, Columbia, SC 29208 USA
[3] Univ S Carolina, Sch Med, Dept Pathol, Columbia, SC 29208 USA
[4] Univ Iowa, Dows Inst, Iowa City, IA 52242 USA
关键词
drug delivery systems; skin alternatives; transdermal drug delivery; permeability;
D O I
10.1023/A:1026405712870
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To test the barrier function of a bio-engineered human skin (BHS) using three model drugs (caffeine, hydrocortisone, and tamoxifen) in vitro. To investigate the lipid composition and microscopic structure of the BHS. Methods. The human skin substitute was composed of both epidermal and dermal layers, the latter having a bovine collagen matrix. The permeability of the BHS to three model drugs was compared to that obtained in other percutaneous testing models (human cadaver skin, hairless mouse skin, and EpiDerm(TM)). Lipid analysis of the BHS was performed by high performance thin layered chromatography. Histological evaluation of the BHS was performed using routine H&E staining. Results. The BHS mimicked human skin in terms of lipid composition, gross ultrastructure, and the formation of a stratum corneum. However, the permeability of the BHS to caffeine, hydrocortisone, and tamoxifen was 3-4 fold higher than that of human cadaver skin. Conclusions. In summary, the results indicate that the BHS may be an acceptable in vitro model for drug permeability testing.
引用
收藏
页码:1092 / 1097
页数:6
相关论文
共 50 条
  • [21] Bio-Engineered Scaffolds Derived from Decellularized Human Esophagus for Functional Organ Reconstruction
    Barbon, Silvia
    Biccari, Andrea
    Stocco, Elena
    Capovilla, Giovanni
    D'Angelo, Edoardo
    Todesco, Martina
    Sandrin, Deborah
    Bagno, Andrea
    Romanato, Filippo
    Macchi, Veronica
    De Caro, Raffaele
    Agostini, Marco
    Merigliano, Stefano
    Valmasoni, Michele
    Porzionato, Andrea
    CELLS, 2022, 11 (19)
  • [22] CLINICAL, HISTOLOGICAL AND HOMEOSTASIS EVALUATION OF AN AUTOLOGOUS TISSUE BIO-ENGINEERED SKIN SUBSTITUTE IN A PATIENT WITH 70% OF TOTAL BODY SURFACE AREA (TBSA) BURN
    Fernandez-Gonzalez, A.
    Lizana-Moreno, A.
    Fernandez, N.
    Guerrero-Calvo, J.
    Ruiz-Garcia, A.
    Espinosa, O.
    Ordonez-Luque, A.
    Sierra-Sanchez, A.
    Arias-Santiago, S.
    CYTOTHERAPY, 2017, 19 (05) : S136 - S136
  • [23] Integrin receptor seeking bio-engineered "smart" magnetic nanomaterials in Lewis lung carcinoma toxicity studies
    Cywinska, Monika A.
    Grudzinski, Ireneusz P.
    Kosmider, Anita
    Poplawska, Magdalena
    Bystrzejewski, Michal
    Cieszanowski, Andrzej
    Fijalek, Zbigniew
    Ostrowska, Agnieszka
    TOXICOLOGY LETTERS, 2013, 221 : S93 - S93
  • [24] The ROC skin model: A robust skin equivalent for permeation and live cell imaging studies
    Jakobsen, Nicoline Dorothea
    Kaiser, Katharina
    Ebbesen, Morten Frendo
    Lauritsen, Line
    Gjerstorff, Morten Frier
    Kuntsche, Judith
    Brewer, Jonathan R.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 178
  • [25] BIO-ENGINEERED, CLINICALLY APPLICABLE SKIN GRAFTS: WHAT DOES IT MEAN TO PRODUCE THEM UNDER GMP CONDITIONS?
    Hartmann-Fritsch, F.
    Meyer, S.
    Sobrio, M.
    Reichmann, E.
    WOUND REPAIR AND REGENERATION, 2014, 22 (05) : A83 - A83
  • [26] Improved Engraftment and Regeneration of Bio-engineered Autologous Skin Grafts Prevascularized with Adipose-derived Stem Cells
    Klar, A. S.
    Gueven, S.
    Biedermann, T.
    Luginbuehl, J.
    Boettcher-Haberzeth, S.
    Meuli-Simmen, C.
    Meuli, M.
    Martin, I.
    Scherberich, A.
    Reichmann, E.
    TISSUE ENGINEERING PART A, 2015, 21 : S67 - S67
  • [27] Evaluation of Skin Permeation of β-Blockers for Topical Drug Delivery
    Chantasart, Doungdaw
    Hao, Jinsong
    Li, S. Kevin
    PHARMACEUTICAL RESEARCH, 2013, 30 (03) : 866 - 877
  • [28] In vitro permeation testing for the evaluation of drug delivery to the skin
    Lane, Majella E.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 201
  • [29] Evaluation of Skin Permeation of β-Blockers for Topical Drug Delivery
    Doungdaw Chantasart
    Jinsong Hao
    S. Kevin Li
    Pharmaceutical Research, 2013, 30 : 866 - 877
  • [30] The use of a bio-engineered human dermal replacement can be effective in the healing of ischaemic diabetic foot ulcers
    Stuart, L
    Garcia, N
    Bevans, J
    Totton, R
    Wiles, PG
    DIABETES, 2000, 49 : A395 - A395